![moca test scoring 2230 moca test scoring 2230](https://www.rarediseaseadvisor.com/wp-content/uploads/sites/25/2022/04/Montreal-cognitive-assessment.jpg)
IntroductionĬognitive impairment is a core feature of schizophrenia 1 that is less amenable to treatment than its two other core features: psychotic symptoms (especially) and negative symptoms. There was a statistically significant difference between participants’ performance on the MMSE and MoCA tests ( p = 0.000008).Ĭonclusion: Compared to the MMSE, the MoCA may be a more useful instrument to detect cognitive impairment in patients with schizophrenia. The mean MMSE score was 27.17 ± 2.64, and the mean MoCA score was 22.53 ± 3.91. Results: The sample consisted of 30 Afrikaans-speaking outpatients with schizophrenia. The MMSE and MoCA scores for each participant were matched and compared using the non-parametric Wilcoxon matched pairs test. Participants had at least seven years of formal education and had been in partial or full remission for at least 3 months.
![moca test scoring 2230 moca test scoring 2230](https://i.pinimg.com/originals/b0/85/fa/b085fa5b272ef4781bab86943e45e6ef.png)
Method: The Afrikaans versions of the MMSE and MoCA were administered to Afrikaans-speaking adult outpatients. The objective of this study was to compare the results of the MMSE and MoCA in a group of outpatient schizophrenia sufferers to contribute to research into the instruments’ potential usefulness as screening tools for cognitive impairment in schizophrenia. Nevertheless, the Montreal Cognitive Assessment Test (MoCA) and the Mini-Mental State Examination (MMSE) show promise in this regard.
![moca test scoring 2230 moca test scoring 2230](https://3.bp.blogspot.com/-wtPkYYbCV94/WRCr4dJ-TvI/AAAAAAAFVJY/wr_OSpdbL8UDUpkRh1-S4pLrZ_yKjBs7ACLcB/s1600/MOCA%2B2.jpeg)
Unfortunately there are no validated, brief screening instruments for the detection of cognitive impairment in schizophrenia. In most clinical settings comprehensive neuropsychological testing to detect cognitive impairment in schizophrenia patients is not readily available, but because cognitive deficits in schizophrenia are clinically important it would be useful to detect or at least screen for them in a clinical setting. This is an Open Access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution,Īnd reproduction in any medium, provided the original work is properly cited.īackground: Cognitive impairment is a core feature of schizophrenia that also has strong prognostic significance. Ī comparison between the Mini-Mental State Examination and the Montreal Cognitive Assessment Test in schizophrenia A comparison between the Mini-Mental State Examination and the Montreal Cognitive Assessment Test in schizophrenia.